Dennis Jilins
Dennis Jilins is a board advisor for Huya Bio, a company focused on biopharmaceutical innovation. He remarked at the 2025 Zhongguancun Forum that China's substantial investments in life sciences research have established a competitive foundation for global participation in the biopharmaceutical industry.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| China | 1 | 7.00 | 0.05% | +0% | 1,402,112,000 | 691,036 | $14,000,000 | 6,900$ |
| Totals | 1 | 1,402,112,000 | 691,036 | $14,000,000 | 6,900$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
China:
Dennis Jilins, a board advisor at Huya Bio, noted the significant investments in life sciences research in China.
7